Insider Transactions in Q3 2022 at Xtant Medical Holdings, Inc. (XTNT)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 25
2022
|
Stavros G. Vizirgianakis Director |
BUY
Grant, award, or other acquisition
|
Direct |
70,776
+1.94%
|
-
|
|
Aug 17
2022
|
Scott C Neils Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,270
-0.31%
|
$0
$0.48 P/Share
|
|
Aug 17
2022
|
Kevin D Brandt Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
4,300
-0.61%
|
$0
$0.48 P/Share
|
|
Aug 16
2022
|
Scott C Neils Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,100
-1.22%
|
$0
$0.48 P/Share
|
|
Aug 16
2022
|
Kevin D Brandt Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
18,700
-2.57%
|
$0
$0.49 P/Share
|
|
Aug 15
2022
|
Matthew Rizzo Director |
BUY
Grant, award, or other acquisition
|
Direct |
215,415
+50.0%
|
-
|
|
Aug 15
2022
|
Jeffrey J Peters Director |
BUY
Grant, award, or other acquisition
|
Direct |
215,415
+32.44%
|
-
|
|
Aug 15
2022
|
Orbimed Advisors LLC Director |
BUY
Other acquisition or disposition
|
Indirect |
430,830
+50.0%
|
-
|
|
Aug 15
2022
|
Scott C Neils Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
251,895
+37.55%
|
-
|
|
Aug 15
2022
|
Robert Mc Namara Director |
BUY
Grant, award, or other acquisition
|
Direct |
215,415
+32.53%
|
-
|
|
Aug 15
2022
|
Michael Eggenberg Director |
BUY
Grant, award, or other acquisition
|
Direct |
215,415
+50.0%
|
-
|
|
Aug 15
2022
|
Kevin D Brandt Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
410,079
+36.08%
|
-
|
|
Aug 15
2022
|
John K Bakewell Director |
BUY
Grant, award, or other acquisition
|
Direct |
215,415
+32.44%
|
-
|